Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

​​NIAID Funding Opportunities List

Last updated on July 2​8, 2016. Newer ite​ms are listed first. Subscribe to Email Alerts for new funding opportunities.

All NIAID-relevant FOAs, RFAs, and PAs are listed here. For contracts, see NIAID Solicitations. For other funding opportunity resources, see Finding Foundations and Other Funding Sources.

Learn How to Use This Page below.

Announcement Number, Title, and Link  Division  Type  Due Date 
PA-16-373, Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases DAIT R21 Standard dates through 2019-07-17.
PA-16-372, Small Grants on Primary Immunodeficiency Diseases DAIT R03 Standard dates through 2019-07-17.
RFA-AI-16-042, Emerging Science and Technology in Transplantation  DAIT U01 2016-10-20
PA-16-319, Administrative Supplements for Research on Dietary Supplements (Admin. Supp.) DAIDS, DAIT, DMID Supp. 2016-10-15
2017-01-15
2017-04-15
PA-16-307, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)  DAIDS, DAIT, DMID F32 Standard dates through 2019-05-08.
PA-16-309, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)  DAIDS, DAIT, DMID F31 Standard dates through 2019-05-08.
PA-16-308, Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) DAIDS, DAIT, DMID F31 Standard dates through 2019-05-08.
PA-16-306, Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)  DAIDS, DAIT, DMID F30 Standard dates through 2019-05-08.
PA-16-305, Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship for Students at Institutions With NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)  DAIDS, DAIT, DMID F30 Standard dates through 2019-05-08.
PA-16-303, PHS 2016-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR)  DAIDS, DAIT, DMID R41/R42 Standard dates through 2017-04-06.
PA-16-302, PHS 2016-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR) DAIDS, DAIT, DMID R43/R44 Standard dates through 2017-04-06.
PA-16-107, Modeling of Infectious Disease Agent Study Research Projects DAIDS, DAIT, DMID R01 Standard dates through 2019-05-08.
PAR-16-297, Native American Research Centers for Health (NARCH) DAIDS, DAIT, DMID S06 2017-06-24
PA-16-289, Research Supplements to Promote Reentry into Biomedical and Behavioral Research Careers (Admin. Supp.) DAIDS, DAIT, DMID Supp. See PA. Through 2019-09-30.
PA-16-287, Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin. Supp.) DAIDS, DAIT, DMID Supp. See PA. Through 2019-05-26.
PA-16-286, Successor-in-Interest (Type 6 Parent) DAIDS, DAIT, DMID Type 6 See PA. Through 2019-05-26.
PA-16-285, Change of Grantee Organization (Type 7 Parent) DAIDS, DAIT, DMID Type 7 See PA. Through 2019-05-26.
RFA-AI-16-038, Silencing of HIV-1 Proviruses DAIDS R61, R33 2016-12-07
PA-16-294, NIH Support for Conferences and Scientific Meetings (Parent R13) DAIDS, DAIT, DMID R13 Standard dates through 2019-05-08.
RFA-AI-16-050, Systems Approach to Immunity and Inflammation DAIT U19 2016-11-02
RFA-AI-16-031, Limited Interaction Targeted Epidemiology (LITE) to Advance HIV Prevention DAIDS UG3, UH3 2016-12-05
PA-16-288, Research Supplements to Promote Diversity in Health-Related Research DAIDS, DAIT, DMID Supp. See PA. Through 2019-09-30.
PAR-16-275, Serious Adverse Drug Reaction Research DAIDS, DAIT, DMID R01 See PAR. Through 2019-09-08.
PAR-16-274, Serious Adverse Drug Reaction Research DAIDS, DAIT, DMID R21 See PAR. Through 2019-09-08.
RFA-HG-16-016, BD2K Open Educational Resources for Skills Development in Biomedical Big Data Science DAIDS, DAIT, DMID R25 2016-08-02
2017-08-02
RFA-AI-16-047, Partnerships for Structure-Based Design of Novel Immunogens for Vaccine Development DMID R01 2016-10-03
PAR-16-269, NIAID Clinical Trial Implementation Grant DAIDS, DAIT, DMID R01 See PAR. Through 2019-05-14.
PAR-16-270, NIAID Clinical Trial Implementation Cooperative Agreement DAIDS, DAIT, DMID U01 See PAR. Through 2019-05-14.
PAR-16-271, NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement DAIDS, DAIT, DMID U44 See PAR. Through 2019-05-14.
PAR-16-272, NIAID Clinical Trial Planning Grant DAIDS, DAIT, DMID R34 See PAR. Through 2019-05-14.
PAR-16-262, Sustained Release of Antivirals for Treatment or P​revention of HIV (SRATP) DAIDS R01 2017-01-04
2018-01-04
2019-01-04
RFA-AI-16-040, Revision Applications for U.S.-South Africa Program for Collaborative Biomedical Research DAIDS, DMID U01 2016-08-02
RFA-AI-16-039, Revision Applications for U.S.-South Africa Program for Collaborative Biomedical Research DAIDS, DMID R01 2016-08-02
PAR-16-254, Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design DAIDS, DAIT, DMID R01 2017-01-11
2018-01-11
2019-01-11
PAR-16-253, Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort DAIT UH2 2016-10-04
2017-10-04
2018-10-04
PAR-16-242, Bioengineering Research Grants (BRG) DAIDS, DAIT, DMID R01 Standard dates through 2019-05-08.
PAR-16-238, Dissemination and Implementation Research in Health DAIDS, DAIT, DMID R01 Standard dates through 2019-05-08.
PAR-16-236, Dissemination and Implementation Research in Health DAIDS, DAIT, DMID R21 Standard dates through 2019-05-08.
PA-16-244, Novel Approaches to Understanding, Preventing, and Treating Lyme Disease and Tickborne Coinfections DMID R21 Standard dates through 2019-09-08.
PA-16-243, Novel Approaches to Understanding, Preventing, and Treating Lyme Disease and Tickborne Coinfections DMID R01 Standard dates through 2019-09-08.
RFA-ES-16-003, BD2K Mentored Career Development Award in Biomedical Big Data Science for Intramural Investigators DAIDS, DAIT, DMID K22 2016-08-01
RFA-ES-16-002, BD2K Mentored Career Development Award in Biomedical Big Data Science for Clinicians and Doctorally Prepared Scientists DAIDS, DAIT, DMID K01 2016-08-01
PA-16-208, The Use of mRNA for an HIV Envelope Vaccine DAIDS R41, R42 Standard dates through 2019-04-06.
PA-16-207, The Use of mRNA for an HIV Envelope Vaccine DAIDS R43, R44 Standard dates through 2019-04-06.
PA-16-206, Midcareer Investigator Award in Patient-Oriented Research (Parent K24) DAIDS, DAIT, DMID K24 Standard dates through 2019-05-08.
PA-16-194, Mentored Quantitative Research Development Award (Parent K25) DAIDS, DAIT, DMID K25 Standard dates through 2019-05-08.
RFA-AI-16-028, Understanding HIV Rebound DAIDS P01 2016-07-29
RFA-AI-16-008, Nonhuman Primate Transplantation Tolerance Cooperative Study Group DAIT U19 2016-08-10
RFA-AI-16-007, Nonhuman Primate Transplantation Tolerance Cooperative Study Group DAIT U01 2016-08-10
PAR-16-203, Lasker Clinical Research Scholars Program DAIDS, DAIT, DMID Si2/R00 2016-08-26
PA-16-200, Academic Research Enhancement Award (Parent R15) DAIDS, DAIT, DMID R15 Standard dates through 2019-05-08.
PA-16-198, Mentored Patient-Oriented Research Career Development Award (Parent K23) DAIDS, DAIT, DMID K23 Standard dates through 2019-05-08.
PA-16-193, NIH Pathway to Independence Award (Parent K99/R00) DAIDS, DAIT, DMID K99/R00 Standard dates through 2019-05-08.
PA-16-191, Mentored Clinical Scientist Research Career Development Award (Parent K08) DAIDS, DAIT, DMID K08 Standard dates through 2019-05-08.
PA-16-190, Mentored Research Scientist Development Award (Parent K01) DAIDS, DAIT, DMID K01 Standard dates through 2019-05-08.
PA-16-186, Tools for Cell Line Identification DAIDS, DAIT, DMID R43, R44 Standard dates through 2019-04-06.
PA-16-184, Strategies for the Improvement of HIV Envelope Protein Expression and Yield DAIDS R43, R44 Standard dates through 2019-04-06.
PA-16-182, Strategies for the Improvement of HIV Envelope Protein Expression and Yield DAIDS R41, R42 Standard dates through 2019-04-06.
PAR-16-171, Innovation for HIV Vaccine Discovery DAIDS R01 2016-08-01
RFA-AI-16-024, Identification of Small Molecules for Sustained-Release Anti-HIV Products DAIDS R01 2016-08-03
PA-16-162, NIH Small Research Grant Program (Parent R03) DAIDS, DAIT, DMID R03 Standard dates through 2019-05-08.
PA-16-161, NIH Exploratory/Developmental Research Grant Program (Parent R21) DAIDS, DAIT, DMID R21 Standard dates through 2019-05-08.
PA-16-160, NIH Research Project Grant (Parent R01) DAIDS, DAIT, DMID R01 Standard dates through 2019-05-08.
RFA-AI-16-034, Partnerships for Countermeasures Against Select Pathogens DMID R01 2016-10-03
RFA-AI-16-025, Prevention Innovation Program III (PIP) DAIDS R01 2016-08-03
PA-16-152, Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) DAIDS, DAIT, DMID T32 September 25 for non-AIDS and January 7 for AIDS-related for NIAID through 2019-01-08.
PA-16-151, Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) DAIDS, DAIT, DMID T35 September 25 for non-AIDS and January 7 for AIDS-related for NIAID through 2019-01-08.
PAR-16-124, Methods for Prevention Packages Program IV (MP3 IV) DAIDS R01 2017-06-07
2018-06-07
RFA-AI-16-001, Immunity in Neonates and Infants DAIDS, DAIT, DMID U01 2016-07-29
PAR-16-117, Increased Knowledge and Innovative Strategies to Reduce HIV Incidence-iKnow Projects DAIDS R01 2017-05-09
2018-05-08
PAR-16-115, Optimization of Monoclonal Antibodies for Eliminating the HIV Reservoir DAIDS R01 See PAR. Through 2019-01-10.
PAR-16-106, Rapid Assessment of Zika Virus (ZIKV) Complications DMID R21 See PAR. Through 2019-03-01.
PAR-16-094, Improvement of Animal Models for Stem Cell-Based Regenerative Medicine DAIDS, DAIT R21 Standard dates through 2019-05-08.
PAR-16-093, Improvement of Animal Models for Stem Cell-Based Regenerative Medicine DAIDS, DAIT R01 Standard dates through 2019-05-08.
NOT-HD-16-004, Notice of NICHD, NINDS, NIDCR, and NIAID's Interest to Prioritize Zika Virus (ZIKV) Research Areas DMID R01
R21
Standard dates through current R01 and R21 Parent Announcements.
NOT-AI-16-026, Notice of NIAID's Interest to Highlight High-Priority Zika Virus (ZIKV) Research Areas DMID R01
R03
R21
R43, R44
Standard dates through current Parent Announcements.
PAR-16-081, International Research Ethics Education and Curriculum Development Award DAIDS R25 2017-05-18
2018-05-17
NOT-TW-16-001, Notice of Information: Parallel Funding Initiative for Collaborative Research Between Investigators in the United States and the State of São Paulo, Brazil DAIDS, DAIT, DMID R01 Standard dates through current Parent R01.
RFA-HL-16-003, Collaborative Projects to Accelerate Research in Organ Fibrosis DAIT R01 2016-10-21
PAR-16-027, SBIR/STTR Commercialization Readiness Pilot (CRP) Program: Technical Assistance and Late Stage Development DAIDS, DAIT, DMID SB1 Standard dates through 2017-04-06.
PAR-15-360, Characterization of Mycobacterial Induced Immunity in HIV-Infected and Uninfected Individuals DAIDS, DAIT, DMID R21 2017-01-11
2018-01-11
PAR-15-330, Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) DAIDS U19 2017-03-09
2018-03-09
PAR-15-328, Ethical, Legal, and Policy Issues in HIV Research With Key Populations DAIDS R01 See PAR. Through 2018-09-09.
PAR-15-327, Ethical, Legal, and Policy Issues in HIV Research With Key Populations DAIDS R21 See PAR. Through 2018-09-08.
PA-15-313, Research to Advance Vaccine Safety DMID R21 Standard dates through 2018-09-08.
PA-15-312, Research to Advance Vaccine Safety DMID R01 Standard dates through 2018-09-08.
PAR-15-288, Direct Phase II SBIR Grants to Support Extended Development, Hardening, and Dissemination of Technologies in Biomedical Computing, Informatics, and Big Data Science DAIDS, DAIT, DMID R44 Standard dates through 2017-04-06.
PAR-15-286, Preapplication: Opportunities for Collaborative Research at the NIH Clinical Center DAIDS, DAIT, DMID X02 2016-12-15
2017-12-15
PAR-15-287, Opportunities for Collaborative Research at the NIH Clinical Center DAIDS, DAIT, DMID U01 2017-04-11
2018-04-11
PAR-15-280, Multidisciplinary Studies of HIV/AIDS and Aging  DAIDS R01 Standard AIDS dates through 2018-09-08.
PAR-15-282, Multidisciplinary Studies of HIV/AIDS and Aging  DAIDS R21 Standard AIDS dates through 2018-09-08.
PA-15-010, Spatial Uncertainty: Data, Modeling, and Communication DAIDS, DAIT, DMID R01 Standard dates through 2018-01-08.
PA-15-011, Spatial Uncertainty: Data, Modeling, and Communication DAIDS, DAIT, DMID R03 Standard dates through 2018-01-08.
PA-15-009, Spatial Uncertainty: Data, Modeling, and Communication DAIDS, DAIT, DMID R21 Standard dates through 2018-01-08.
PAR-15-275, Ethical Issues in Research on HIV/AIDS and Its Comorbidities DAIDS R21 See PAR. Through 2018-01-09.
PAR-15-274, Ethical Issues in Research on HIV/AIDS and Its Comorbidities DAIDS R01 See PAR. Through 2018-01-09.
PA-15-273, Harnessing Big Data to Halt HIV DAIDS R01 Standard AIDS dates through 2018-05-08.
PA-15-272, Exploiting RNA as a Target for HIV Interventions DAIDS R21 Standard AIDS dates through 2018-05-08.
PA-15-268, Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation DAIDS R34 Standard AIDS dates through 2018-05-08.
PA-15-263, The Health of Sexual and Gender Minority (SGM) Populations DAIDS, DAIT, DMID R21 Standard dates through 2018-05-08.
PA-15-262, The Health of Sexual and Gender Minority (SGM) Populations DAIDS, DAIT, DMID R03 Standard dates through 2018-09-08.
PA-15-261, The Health of Sexual and Gender Minority (SGM) Populations DAIDS, DAIT, DMID R01 Standard dates through 2018-09-08.
PA-15-260, The Health of Sexual and Gender Minority (SGM) Populations DAIDS, DAIT, DMID R15 Standard dates through 2018-09-08.
PAR-15-164, HIV Vaccine Research and Design (HIVRAD) Program  DAIDS P01 2017-07-14
PAR-15-131, Global Infectious Disease Research Administration Development Award for Low- and Middle-Income Country Institutions DAIDS, DAIT, DMID G11 2017-07-14
PAR-15-130, Investigations on Primary Immunodeficiency Diseases DAIT R01 Standard dates through 2018-05-08.
PA-15-107, Role of Exosomes in HIV Pathogenesis DAIDS R21 Standard dates through 2018-01-08.
PA-15-105, Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity DAIDS R01 Standard AIDS dates through 2018-01-08.
PA-15-106, Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity DAIDS R21 Standard AIDS dates through 2018-01-08.
PA-15-065, Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) DAIT R43, R44 Standard dates through 2018-01-08.
PAS-15-055, High-Priority Immunology Grants DAIT R01 Standard dates through 2018-01-08.
PAR-15-041, Targeting Persistent HIV Reservoirs (TaPHIR) DAIDS R21, R33 2017-04-07
PA-15-027, Research on Eosinophil-Associated Disorders DAIT R01 Standard dates through 2018-01-08.
PA-15-028, Research on Eosinophil-Associated Disorders DAIT R21 Standard dates through 2018-01-08.
PA-14-308, Platform Delivery Technologies for Nucleic Acid Therapeutics DAIDS R41, R42 Standard dates through 2016-09-08.
PA-14-307, Platform Delivery Technologies for Nucleic Acid Therapeutics DAIDS R43, R44 Standard dates through 2016-09-08.
PAR-14-341, NIAID Career Transition Award DAIDS, DAIT, DMID K22 Standard dates through 2017-09-08.
PAR-14-317, Role of the Microbiome in HIV-1 Vaccine Responses DAIDS R01 2017-01-07
PAR-14-318, Role of the Microbiome in HIV-1 Vaccine Responses DAIDS R21 2017-01-07
PA-14-278, Ethical, Legal, and Social Implications (ELSI) of Genomic Research Regular Research Program DAIDS, DAIT, DMID R21 Standard dates through 2017-09-08.
PA-14-277, Ethical, Legal, and Social Implications (ELSI) of Genomic Research Regular Research Program DAIDS, DAIT, DMID R03 Standard dates through 2017-09-08.
PA-14-276, Ethical, Legal, and Social Implications (ELSI) of Genomic Research Regular Research Program DAIDS, DAIT, DMID R01 Standard dates through 2017-09-08.
PAR-14-255, Multidisciplinary Studies of HIV and Viral Hepatitis Coinfection DAIDS R01 Standard AIDS dates through 2017-05-08.
PAR-14-254, Multidisciplinary Studies of HIV and Viral Hepatitis Coinfection DAIDS R21 Standard AIDS dates through 2017-05-08.
PAR-14-247, Basic Research on HIV Persistence DAIDS R01 Standard AIDS dates through 2017-01-08.
PAR-14-248, Basic Research on HIV Persistence DAIDS R21 Standard AIDS dates through 2017-01-08.
PA-14-215, HIV Vaccine Vector-Host Interactions: Understanding the Biology and Immunology DAIDS R01 Standard AIDS dates through 2017-01-08.
PA-14-214, HIV Vaccine Vector-Host Interactions: Understanding the Biology and Immunology DAIDS R21 Standard AIDS dates through 2017-01-08.
PA-14-218, Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery DAIDS R01 Standard AIDS dates through 2017-01-08.
PA-14-217, NK Cells to Induce Immunological Memory to Prevent HIV Infection DAIDS R01 Standard AIDS dates through 2017-01-08.
PAR-14-193, Global Infectious Disease Research Training Program DMID D43 2016-07-29
PA-14-179, Clinical Trial Planning Grant for Interventions and Services to Improve Treatment and Prevention of HIV/AIDS DAIDS R34 Standard AIDS dates through 2017-01-08.
PA-14-157, Early-Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science DAIDS, DAIT, DMID R41, R42 Standard dates through 2017-05-08.
PA-14-154, Early-Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science DAIDS, DAIT, DMID R43, R44 Standard dates through 2017-05-08.
PA-14-134, Advancing Structural Level Interventions Through Enhanced Understanding of Social Determinants in HIV Prevention and Care DAIDS R21 Standard AIDS dates through 2017-01-08.
PA-14-133, Advancing Structural Level Interventions Through Enhanced Understanding of Social Determinants in HIV Prevention and Care DAIDS R01 Standard AIDS dates through 2017-01-08.
PA-14-132, Accelerating Improvements in the HIV Care Continuum DAIDS R01 Standard AIDS dates through 2017-01-08.
PA-14-131, Improving Delivery of HIV Prevention and Treatment Through Implementation Science and Translational Research DAIDS R01 Standard AIDS dates through 2017-01-08.
PA-14-130, Accelerating Improvements in the HIV Care Continuum DAIDS R21 Standard AIDS dates through 2017-01-08.
PA-14-129, Improving Delivery of HIV Prevention and Treatment Through Implementation Science and Translational Research DAIDS R21 Standard AIDS dates through 2017-01-08.
PA-14-128, Targeted Basic Behavioral and Social Science and Intervention Development for HIV Prevention and Care DAIDS R21 Standard AIDS dates through 2017-01-08.
PA-14-127, Targeted Basic Behavioral and Social Science and Intervention Development for HIV Prevention and Care DAIDS R01 Standard AIDS dates through 2017-01-08.
PA-14-126, Strengthening Adherence to Antiretroviral-Based HIV Prevention and Treatment DAIDS R01 Standard AIDS dates through 2017-01-08.
PA-14-125, Strengthening Adherence to Antiretroviral-Based HIV Treatment and Prevention DAIDS R21 Standard AIDS dates through 2017-01-08.
PA-14-102, Innovative Technologies and Assays in Support of HIV Cure Research (ITAS-Cure) DAIDS R41, R42 Standard dates through 2017-01-08.
PA-14-101, Innovative Technologies and Assays in Support of HIV Cure Research (ITAS-Cure) DAIDS R43, R44 Standard dates through 2017-01-08.
PA-14-095, Eradication of HIV-1 From Central Nervous System Reservoirs DAIDS R01 Standard AIDS dates through 2017-01-08.
PA-14-094, HIV Infection of the Central Nervous System DAIDS R01 Standard AIDS dates through 2017-01-08.
PAR-14-088, Direct Phase II SBIR Grants to Support Biomedical Technology Development DAIDS, DAIT, DMID R44 Standard dates through 2017-01-08.
PAR-14-080, International Research in Infectious Diseases, Including AIDS DMID R01 See PAR. Through 2016-08-20.
PAR-14-041, Centers for AIDS Research and Developmental Centers for AIDS Research DAIDS P30 2016-07-28
PAR-14-019, Support of Competitive Research (SCORE) Research Advancement Award DAIDS, DAIT, DMID SC1 See PAR. Through 2016-09-08.
PAR-14-017, Support of Competitive Research (SCORE) Pilot Project Award DAIDS, DAIT, DMID SC2 See PAR. Through 2016-09-08.
PAR-13-364, Development of Assays for High-Throughput Screening for Use in Probe and Pretherapeutic Discovery DAIDS, DAIT, DMID R01 Standard dates through 2017-01-08.
PA-13-313, Academic Research Enhancement Award (Parent R15) DAIDS, DAIT, DMID R15 Standard dates through 2016-09-08.
PAR-13-254, NIAID Investigator-Initiated Program Project Applications DAIDS, DAIT, DMID P01 Standard dates through 2016-09-08.
PAR-13-242, NIAID Resource-Related Research Projects DAIDS, DAIT, DMID R24 Standard dates through 2016-09-08.
RFP—Requests for proposals are not included in this list. Find them here: NIAID Solicitations. DAIDS, DAIT, DMID Contract N/A
BAA—Broad agency announcements are not included in this list. Find them here: NIAID Solicitations. DAIDS, DAIT, DMID Contract N/A
Common Fund—Common Fund announcements are not included in this list. Find them here: Common Fund in the NIH Guide. DAIDS, DAIT, DMID Common Fund N/A
Roadmap—Roadmap announcements (now called Common Fund) are not included in this list. Find them here: Common Fund in the NIH Guide. DAIDS, DAIT, DMID Roadmap N/A

How to Use the Funding Opportunities Page

  • This page lists NIAID-related initiatives posted in the NIH Guide. The NIH Guide, Grants.gov, and FedBizOpps are the official sources for NIH announcements.
  • For amendments, check the Guide notice for your FOA regularly. Amendments are listed there.
  • Contract solicitations (RFP, BAA) are not listed here. Instead, see NIAID Solicitations.
  • All announcements are open to applicants from the private and public sectors, including small businesses. ​​​​​​​​​​​​​​​
​ ​​​​​​ ​​​​​​​​​​​​​​​​​ ​​ ​ ​​ ​​​ ​ ​​​​​​​​

Last Updated July 28, 2016

Last Reviewed July 28, 2016